Search Result

Search Results for " lib "

Targets

CDK

108

Compounds

Natural Products

Recombinant Proteins

193

Libraries

Cat No.	Product Name	Synonyms	Targets
T13467	(±)-Enitociclib	(±)-BAY-1251152	CDK
	(±)-Enitociclib ((±)-BAY-1251152) is a racemic mixture of BAY-1251152. BAY-1251152 is highly selective inhibitor of PTEF/CDK9.		CDK
T15012	Crolibulin	EPC2407	Microtubule Associated
	Crolibulin (EPC2407) is an inhibitor of small molecule tubulin polymerization.		Microtubule Associated
T10220	Abemaciclib metabolite M2	Abemaciclib Metabolites M2	CDK
	Abemaciclib Metabolites M2 is a metabolite of abemaciclib, acts as a potent CDK4 and CDK6 inhibitor (IC50s: 1-3 nM) with anti-cancer activity.		CDK
T10464L	Atuveciclib Racemate	BAY-1143572 Racemate	CDK
	Atuveciclib Racemate (BAY-1143572 Racemate) is the racemate mixture of Atuveciclib, which is a potent and highly selective, oral P-TEFb/CDK9 inhibitor which supresses CDK9/CycT1 with an IC50 of 13 nM.		CDK
T10898	Samuraciclib hydrochloride	ICEC0942 hydrochloride,CT7001 hydrochloride	Apoptosis , CDK
	Samuraciclib hydrochloride (ICEC0942 hydrochloride) is a potent, selective, ATP competitive and oral active CDK7 inhibitor with IC50 of 41 nM. The selectivity of Samuraciclib hydrochloride is 45-, 15-, 230- and 30-fold h...		Apoptosis , CDK
T3207	Briciclib	ON 014185	CDK , PERK , Autophagy
	Briciclib (ON 014185) is a small molecule that suppresses cyclin D1 accumulation in Y cells.		CDK , PERK , Autophagy
T6375	Alibendol	cebera,EB 1856	Others
	Alibendol (cebera) is a choleretic, antispasmodic, and cholekinetic.		Others
T2381	Abemaciclib	CDK4/6 dual inhibitor,LY2835219	CDK
	Abemaciclib (LY2835219) is a dual inhibitor of CDK4/6 (IC50=2/10 nM) with selectivity and specificity. Abemaciclib has antitumor activity and is used to treat advanced or metastatic breast cancer.		CDK
T1912	Dinaciclib	SCH 727965,PS-095760	Apoptosis , CDK
	Dinaciclib (SCH 727965) is a CDK inhibitor that selectively inhibits CDK1, CDK2, CDK5, and CDK9 (IC50 score = 3/1/1/4 nM). Dinaciclib has potential antitumor activity and inhibits the incorporation of thoracic glycan (dT...		Apoptosis , CDK
T39403	Avotaciclib	BEY1107,Avotaciclib	CDK
	Avotaciclib (BEY1107) is a potent and orally active cyclin dependent kinase 1 (CDK1) inhibitor.Avotaciclib can be used to study locally advanced or metastatic pancreatic cancer.		CDK
T27827	Libenzapril	CGS 16617,Abutapril	Angiotensin-converting Enzyme (ACE)
	Libenzapril (CGS 16617) is a potent angiotensin-converting enzyme inhibitor used to study myocardial injury.		Angiotensin-converting Enzyme (ACE)
T23557	Talibegron hydrochloride	ZD2079 hydrochloride,ZD 2079	Adrenergic Receptor
	Talibegron hydrochloride (ZD2079 hydrochloride) is an β3 adrenergic receptor agonist with a pD2 of 3.72 on phenylephrine-preconstricted rat mesenteric artery. Relaxes rat mesenteric artery and isolated aorta in vitro. In...		Adrenergic Receptor
T6239	Palbociclib monohydrochloride	PD 0332991 hydrochloride,Palbociclib hydrochloride,Palbociclib (PD-0332991) HCl	CDK
	Palbociclib monohydrochloride (PD 0332991 hydrochloride) is a selective inhibitor of CDK4/6 (IC50s: 11/16 nM). It exhibits no inhibition against a panel of 36 additional protein kinases.		CDK
T3111	Abemaciclib methanesulfonate	abemaciclib mesylate,LY2835219,LY2835219 mesylate,LY2835219 (methanesulfonate)	CDK
	Abemaciclib methanesulfonate (LY2835219) is a specific and effective inhibitor of CDK4(IC50=2 nM) and CDK6(IC50=10 nM).		CDK
T15385	Glibornuride		Potassium Channel
	Glibornuride is an ATP-sensitive K+ channels (KATP channel) blocker ( pKi: 5.75). It is an antidiabetic agent.		Potassium Channel
T9636	Dalpiciclib	SHR-6390	CDK
	Dalpiciclib (SHR-6390) is a highly selective, orally bioavailable, and comparable potency inhibitor of CDK4 and CKD6 with IC50s of 12.4 nM and 9.9 nM, respectively. Dalpiciclib exerts potent antitumor activity in esophag...		CDK
T13202	Trilaciclib hydrochloride	G1T28 hydrochloride	CDK
	Trilaciclib hydrochloride (G1T28 hydrochloride) is an inhibitor of CDK4/6 (IC50s: 1 nM and 4 nM for CDK4 and CDK6).		CDK
T13044	Mevociclib	SY-1365	CDK
	Mevociclib (SY-1365) is a highly selective covalent inhibitor of CDK7. SY-1365 possesses therapeutic potential in both hematological and solid tumors.		CDK
T6081	Milciclib	PHA-848125	Trk receptor , CDK , Autophagy
	Milciclib (PHA-848125) (PHA-848125) is a potent, ATP-competitive CDK inhibitor for CDK2 with IC50 of 45 nM. It is >3-fold more selective for CDK2 than CDK1, 2, 4, 5, and 7. Phase 2.		Trk receptor , CDK , Autophagy
T4297	Flibanserin	BIMT-17BS,Girosa,BIMT-17	Dopamine Receptor , 5-HT Receptor
	Flibanserin (Girosa) is a serotonergic antidepressant used to treat hypoactive sexual desire disorder. Flibanserin has been associated with a low rate of minor serum aminotransferase elevations during treatment but has n...		Dopamine Receptor , 5-HT Receptor
T11345L	Lerociclib dihydrochloride	G1T38 dihydrochloride	CDK
	Lerociclib dihydrochloride (G1T38 dihydrochloride) is a potent and selective inhibitor of CDK4/CDK6, with IC50s of 2 nM and 1 nM for CDK6/CyclinD3 and CDK4/CyclinD1, respectively.		CDK
T15732	Ribociclib succinate	LEE011 succinate	CDK
	Ribociclib succinate (LEE011 succinate) is a highly specific CDK4/6 inhibitor (IC50: 10 nM and 39 nM, respectively). It also is over 1,000-fold less potent against the cyclin B/CDK1 complex.		CDK
T1906	Molibresib	GSK 525762A,GSK525762,I-BET 762	Epigenetic Reader Domain
	Molibresib (GSK525762) is an inhibitor of BET proteins (IC50: about 35 nM).		Epigenetic Reader Domain
T6240	Palbociclib Isethionate	Palbociclib (PD0332991) Isethionate,PD 0332991 isethionate	CDK
	Palbociclib Isethionate (PD 0332991 isethionate) is a selective inhibitor of CDK4/6 (IC50s: 11/16 nM). It exhibits no inhibition against a panel of 36 additional protein kinases.		CDK
T6924	Riviciclib hydrochloride	P276-00	Apoptosis , CDK
	Riviciclib hydrochloride (P276-00) is a novel CDK1, CDK4 and CDK9 inhibitor with IC50 of 79 nM, 63 nM and 20 nM, respectively. Phase 2/3.		Apoptosis , CDK
T60025	Eciruciclib		CDK
	Eciruciclib is an inhibitor of CDK with antitumor properties.		CDK
TQ0053	Fadraciclib	CYC065	CDK
	Fadraciclib (CYC065) is an orally available, second-generation ATP-competitive inhibitor of CDK2/CDK9 kinases (IC50s: 5/26 nM).		CDK
T10738	Abemaciclib metabolite M20	CDK4/6-IN-4,LSN3106726	CDK
	Abemaciclib metabolite M20 (CDK4/6-IN-4) is an active metabolite of Abemaciclib. Abemaciclib metabolite M20 is a selective CDK4/6 inhibitor and can be used for researches on the treatment of cancer.		CDK
T1634	Glibenclamide	Glyburide	Potassium Channel , Mitochondrial Metabolism , CFTR , P-gp , Autophagy
	Glibenclamide (Glyburide) is an antidiabetic sulfonylurea derivative with actions similar to those of chlorpropamide.
T1785	Palbociclib	PD 0332991	CDK
	Palbociclib (PD 0332991) is a CDK inhibitor that inhibits CDK4 and CDK6 (IC50=11/16 nM) and is orally active. Palbociclib has anti-tumorigenic activity and has investigational potential for use in ER-positive and HER2-ne...		CDK
T6199	Ribociclib	LEE011	VEGFR , CDK
	Ribociclib (LEE011) is an orally available, and highly specific CDK4/6 inhibitor (IC50：10/39 nM).		VEGFR , CDK
T2095	Seliciclib	Roscovitine,R-roscovitine,CYC202	CDK
	Seliciclib (Roscovitine) is a potent inhibitor of Cdk2/cyclin E (IC50: 0.1 μM). It also inhibits Cdk7/cyclin H, Cdk5/p35, and Cdc2/cyclin B (IC50s: 0.49/0.16/0.65 μM).		CDK
T21503	(E/Z)-Zotiraciclib	(E/Z)-TG02,(E/Z)-SB1317	FLT , JAK , CDK
	(E/Z)-Zotiraciclib ((E/Z)-TG02) inhibits CDK2, JAK2, and FLT3 effectively with IC50s of 13, 73, and 56 nM, respectively.		FLT , JAK , CDK
T15282	Filibuvir	PF-00868554	HCV Protease , DNA/RNA Synthesis
	Filibuvir (PF-00868554) is a selective and noncovalent inhibitor of HCV NS5B RNA-dependent RNA polymerase. Filibuvir inhibits genotype 1a and 1b replicons with EC50s of 59 nM.		HCV Protease , DNA/RNA Synthesis
T70388L	(R)-Enitociclib		CDK
	(R)-Enitociclib, an enantiomer of BAY-1251152, is a CDK9 inhibitor with anticancer activity.		CDK
T70388	(S)-Enitociclib	VIP152	CDK
	(S)-Enitociclib (VIP152) is a selective CDK9 inhibitor that induces complete regression of MYC+ lymphomas by inhibiting RNA polymerase II-mediated transcription of anti-apoptotic and pro-survival proteins.		CDK
T19668	Tiomolibdate diammonium	Ammonium molybdenum sulfide,Ammonium tetrathiomolybdate,NSC 286644,ATTM,Coprexa	Others
	Tiomolibdate diammonium (NSC-286644) is an inhibitor of superoxide dismutase 1 (SOD1) exerting antiangiogenic and antitumor activities. Tiomolibdate diammonium inhibits the activities of cuproenzymes, including SOD1 and ...		Others
T10096L	Voruciclib		CDK
	Voruciclib is an orally active and selective CDK inhibitor (Ki: 0.626 nM-9.1 nM). Voruciclib represses the expression of MCL-1 in multiple models of diffuse large B-cell lymphoma. Voruciclib effectively blocks CDK9, the ...		CDK
T63650	Samuraciclib hydrochloride hydrate
	Samuraciclib (CT7001) hydrochloride hydrate is a potent, selective, ATP-competitive, orally active inhibitor of CDK7 (IC50: 41 nM). Samuraciclib hydrochloride hydrate inhibits the growth of breast cancer cell lines (GI50...
T64486	6-Desacetyl Palbociclib
	6-Desacetyl Palbociclib is a useful organic compound for research related to life sciences and the catalog number is T64486.
T70897	Zotiraciclib HCl
	Zotiraciclib, also known as TG02 and SB1317, is a novel small molecule potent CDK/JAK2/FLT3 inhibitor. Zotiraciclib may be useful for the treatment of cancer that crosses the blood brain barrier and acts by depleting M...
T68506	Briciclib Na
	Briciclib Na inhibits benzylstyryl sulfone kinase and is use for the treatment of Cancer
T41207	Tocriscreen Stem Cell Library
	The Tocriscreen Stem Cell Library is a bioactive compound library composed of 120 compounds supplied in DMSO (100 μL 10 mM solutions). This compound library contains a diverse range of small molecules to find the best co...
T32738	Libecillide
	Libecillide is a bioactive chemical.
T70014	Avotaciclib sulfate
	Avotaciclib sulfate is a cyclin-dependent kinase inhibitor and antineoplastic.
T72507	Palbociclib orotate	PD 0332991 orotate	CDK
	Palbociclib (PD 0332991) orotate, an orally active selective inhibitor of CDK4 and CDK6, exhibits IC50 values of 11 and 16 nM, respectively. This compound demonstrates potent anti-proliferative effects and induces cell c...		CDK
T12737	Riviciclib	P276-00 (free base)	Others
	Riviciclib is a potent inhibitor of cyclin-dependent kinase (CDK)(CDK9-cyclinT1, CDK4-cyclin D1, and CDK1-cyclinB with IC50s of 20 nM, 63 nM, and 79 nM, respectively),with antitumor activity on cisplatin-resistant cells.		Others
T15731	Ribociclib succinate hydrate	LEE011 succinate hydrate	CDK
	Ribociclib succinate hydrate is a highly specific CDK4/6 inhibitor (IC50s: 10 nM and 39 nM, respectively). It also is over 1,000-fold less potent against the cyclin B/CDK1 complex.		CDK
T16752	Rimacalib	SMP 114	CaMK
	Rimacalib is an inhibitor of Ca2+/calmodulin-dependent protein kinase II (IC50s: ~1 μM for CaMKIIα and ~30 μM for CaMKIIγ).		CaMK
T13202L	Trilaciclib	G1T28	CDK
	Trilaciclib is an inhibitor of CDK4/6 (IC50s: 1 nM and 4 nM for CDK4 and CDK6, respectively).		CDK

Compounds

(±)-Enitociclib

T13467

Synonym: (±)-BAY-1251152

Target: Microtubule Associated

Abemaciclib metabolite M2

T10220

Synonym: Abemaciclib Metabolites M2

Target: CDK

Atuveciclib Racemate

T10464L

Synonym: BAY-1143572 Racemate

Target: CDK

Samuraciclib hydrochloride

T10898

Synonym: ICEC0942 hydrochloride,CT7001 hydrochloride

Target: Apoptosis, CDK

Briciclib

T3207

Synonym: ON 014185

Target: CDK, PERK, Autophagy

Alibendol

T6375

Synonym: cebera,EB 1856

Target: Others

Abemaciclib

T2381

Synonym: CDK4/6 dual inhibitor,LY2835219

Target: CDK

Dinaciclib

T1912

Synonym: SCH 727965,PS-095760

Target: Apoptosis, CDK

Avotaciclib

T39403

Synonym: BEY1107,Avotaciclib

Target: CDK

Libenzapril

T27827

Synonym: CGS 16617,Abutapril

Target: Angiotensin-converting Enzyme (ACE)

Talibegron hydrochloride

T23557

Synonym: ZD2079 hydrochloride,ZD 2079

Target: Adrenergic Receptor

Palbociclib monohydrochloride

T6239

Synonym: PD 0332991 hydrochloride,Palbociclib hydrochloride,Palbociclib (PD-0332991) HCl

Target: CDK

Abemaciclib methanesulfonate

T3111

Synonym: abemaciclib mesylate,LY2835219,LY2835219 mesylate,LY2835219 (methanesulfonate)

Target: Potassium Channel

Trilaciclib hydrochloride

T13202

Synonym: G1T28 hydrochloride

Target: Trk receptor, CDK, Autophagy

Flibanserin

T4297

Synonym: BIMT-17BS,Girosa,BIMT-17

Target: Dopamine Receptor, 5-HT Receptor

Lerociclib dihydrochloride

T11345L

Synonym: G1T38 dihydrochloride

Target: CDK

Ribociclib succinate

T15732

Synonym: LEE011 succinate

Target: CDK

Molibresib

T1906

Synonym: GSK 525762A,GSK525762,I-BET 762

Target: Epigenetic Reader Domain

Palbociclib Isethionate

T6240

Synonym: Palbociclib (PD0332991) Isethionate,PD 0332991 isethionate

Target: CDK

Riviciclib hydrochloride

T6924

Synonym: P276-00

Target: Apoptosis, CDK

Abemaciclib metabolite M20

T10738

Synonym: CDK4/6-IN-4,LSN3106726

Target: Potassium Channel, Mitochondrial Metabolism, CFTR, P-gp, Autophagy

Synonym: Roscovitine,R-roscovitine,CYC202

Target: CDK

(E/Z)-Zotiraciclib

T21503

Synonym: (E/Z)-TG02,(E/Z)-SB1317

Target: FLT, JAK, CDK

Filibuvir

T15282

Synonym: PF-00868554

Target: HCV Protease, DNA/RNA Synthesis

Tiomolibdate diammonium

T19668

Synonym: Ammonium molybdenum sulfide,Ammonium tetrathiomolybdate,NSC 286644,ATTM,Coprexa

Samuraciclib hydrochloride hydrate

T63650

Synonym:

Target:

6-Desacetyl Palbociclib

Tocriscreen Stem Cell Library

Synonym: PD 0332991 orotate

Target: CDK

Riviciclib

T12737

Synonym: P276-00 (free base)

Target: Others

Ribociclib succinate hydrate

T15731

Synonym: LEE011 succinate hydrate

Cat No.	Product Name	Synonyms	Targets
T2914	D-Melibiose	Galalpha1-6Glcbeta,Melibiose	Others , Endogenous Metabolite
	D-Melibiose (Galalpha1-6Glcbeta) is a reducing disaccharide formed by an alpha-1, 6 linkage between galactose and glucose (D-Gal-α(1→6)-D-Glc).		Others , Endogenous Metabolite
T1660	Silibinin	Silibinin A,Silybin,Silymarin I	Reactive Oxygen Species , Autophagy
	Silibinin (Silybin) is the major active constituent of silymarin, a standardized extract of the milk thistle seeds, containing a mixture of flavonolignans consisting of silibinin, isosilibinin, silicristin, silidianin an...		Reactive Oxygen Species , Autophagy
T6723	Voglibose	AO 128,Glustat,Basen	Glucosidase
	Voglibose (Glustat), an N-substituted derivative of valiolamine, exhibits excellent inhibitory activity against α-glucosidases and action against hyperglycemia and various disorders caused by hyperglycemia.		Glucosidase
T24225	Julibrine I
	Julibrine I is a bioactive chemical.
TN6103	Thalibealine
	Thalibealine is a natural product for research related to life sciences. The catalog number is TN6103 and the CAS number is 351531-39-0.
T32740	Libramycin A
	Libramycin A is a fat-soluble, weakly acidic substance extracted from Streptomyces.
T24226	Julibrine II
	Julibrine II is a bioactive chemical. It also exhibits arrhythmic-inducing action.

Natural Products

D-Melibiose

T2914

Synonym: Galalpha1-6Glcbeta,Melibiose

Target: Others, Endogenous Metabolite

Silibinin

T1660

Synonym: Silibinin A,Silybin,Silymarin I

Target: Reactive Oxygen Species, Autophagy

Voglibose

T6723

Synonym: AO 128,Glustat,Basen

Recombinant Proteins

Species：

Expression System：

Tag：

Cat No.	Product Name	Species	Expression System
TMPY-04333	LRRC15 Protein, Human, Recombinant (hFc)	Human	HEK293 Cells
	LRRC15 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells with hFc tag. The predicted molecular weight is 84.5 kDa and the accession number is Q8TF66-1.
TMPK-01309	LRRC15 Protein, Canine, Recombinant (His)	Canine	HEK293 Cells
	The chimeric protein binds in vitro and in vivo to a specific element upstream of LRRC15, leading to dramatic transcriptional activation. LRRC15 encodes a leucine-rich transmembrane protein, present at the leading edge ...
TMPK-01070	LRRC15 Protein, Mouse, Recombinant (His)	Mouse	HEK293 Cells
	The chimeric protein binds in vitro and in vivo to a specific element upstream of LRRC15, leading to dramatic transcriptional activation. LRRC15 encodes a leucine-rich transmembrane protein, present at the leading edge ...
TMPK-00338	LRRC15 Protein, Human, Recombinant (His & Avi)	Human	CHO Cells
	The chimeric protein binds in vitro and in vivo to a specific element upstream of LRRC15, leading to dramatic transcriptional activation. LRRC15 encodes a leucine-rich transmembrane protein, present at the leading edge ...
TMPK-01380	LRRC15 Protein, Cynomolgus/Rhesus macaque, Recombinant (His)	Cynomolgus,Rhesus	HEK293 Cells
	The chimeric protein binds in vitro and in vivo to a specific element upstream of LRRC15, leading to dramatic transcriptional activation. LRRC15 encodes a leucine-rich transmembrane protein, present at the leading edge ...
TMPY-06148	LRRC15 Protein, Human, Recombinant (His)	Human	HEK293 Cells
	LRRC15 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 59.2 kDa and the accession number is Q8TF66-1.
TMPY-06919	LRRC15 Protein, Mouse, Recombinant (His & Avi), Biotinylated	Mouse	HEK293 Cells
	LRRC15 Protein, Mouse, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with His and Avi tag. The predicted molecular weight is 60.74 kDa and the accession number is NP_083249.1.
TMPJ-00338	LRRC15 Protein, Human, Recombinant (His & Avi), Biotinylated	Human	HEK293 Cells
	The type I transmembrane protein 15-leucine-rich repeat containing membrane protein (LRRC15) is a member of the LRR superfamily. The LRR family is a structural module for protein-protein and protein-matrix interactions u...
TMPH-02608	Corticoliberin Protein, Mouse, Recombinant (His & KSI)	Mouse	E. coli
	Hormone regulating the release of corticotropin from pituitary gland. Induces NLRP6 in intestinal epithelial cells, hence may influence gut microbiota profile.
TMPH-03354	Progonadoliberin-1/GNRH1 Protein, Rat, Recombinant (His)	Rat	E. coli
	Stimulates the secretion of gonadotropins; it stimulates the secretion of both luteinizing and follicle-stimulating hormones. Progonadoliberin-1/GNRH1 Protein, Rat, Recombinant (His) is expressed in E. coli expression sy...

LRRC15 Protein, Human, Recombinant (hFc)

TMPY-04333

Species: Human

Expression System: HEK293 Cells

LRRC15 Protein, Canine, Recombinant (His)

TMPK-01309

Species: Canine

Expression System: HEK293 Cells

LRRC15 Protein, Mouse, Recombinant (His)

TMPK-01070

Species: Mouse

Expression System: HEK293 Cells

LRRC15 Protein, Human, Recombinant (His & Avi)

TMPK-00338

Species: Human

Expression System: CHO Cells

LRRC15 Protein, Cynomolgus/Rhesus macaque, Recombinant (His)

TMPK-01380

Species: Cynomolgus,Rhesus

Expression System: HEK293 Cells

LRRC15 Protein, Human, Recombinant (His)

TMPY-06148

Species: Human

Expression System: HEK293 Cells

LRRC15 Protein, Mouse, Recombinant (His & Avi), Biotinylated

TMPY-06919

Species: Mouse

Expression System: HEK293 Cells

LRRC15 Protein, Human, Recombinant (His & Avi), Biotinylated

TMPJ-00338

Species: Human

Expression System: HEK293 Cells

Corticoliberin Protein, Mouse, Recombinant (His & KSI)

TMPH-02608

Species: Mouse

Expression System: E. coli

Progonadoliberin-1/GNRH1 Protein, Rat, Recombinant (His)

TMPH-03354

Species: Rat

Expression System: E. coli

Cat No.	Product Name
L1000	Approved Drug Library	2808 compounds
	A unique collection of 2808 approved drugs for high throughput screening (HTS) and high content screening (HCS);
L7000	Bioactive Lipid Compound Library	385 compounds
	A unique collection of 385 bioactive lipids related compounds for high throughput screening (HTS) and high content screening (HCS), including Agonists & Antagonists, Endocannabinoids, Farnesyl/geranylgeranyl derivates, ...
VM1400	Diversity Core Library Part2	25920 compounds

DO1200	SmartTM Library	53200 compounds

L7860	Mini Electrophilic Heterocyclic Fragment Library	369 compounds
	369 compounds in total in the Highly Solubility Covalent Heterocyclic Fragment Library
L5700	Featured Fragment Library	246 compounds
	A unique collection of 246 fragment-like small molecules for FBDD;
L1120	AMPK-Targeted Compound Library	80 compounds
	80 well-chosen unique AMPK-targeted small molecules；
L5610	Golden Scaffold Library	10000 compounds
	Diversity: Selected from 1,600,000 drug-like compounds, 10000compounds representing 5000 scaffolds selected from a large drug-like chemical source；
L7810	High Solubility Polyfunctional Group Fragment Library	1159 compounds
	Highly soluble multifunctional fragment library contains 1159 kinds of fragment molecules.
L6020	Selectable Natural Product Library	16627 compounds
	A unique collection of 16627 pure natural products with diverse structures and sources covering various plant, animal, and microbe species;
NY1000	Natural Product Derivatives Library	4000 compounds
	The library consists of more than 4,000 members belonging 22 scaffolds (average 180 compounds per scaffold).
L4660	Anti-Nervous System Disease Library	1246 compounds
	Well-chosen 1246 compounds with unique structures targeting nervous system;
L6001	Mini Fungal Metabolite Natural Product Screening Library	Inquiry

L3200	Autophagy Compound Library	1248 compounds
	A unique collection of 1248 compounds with defined autophagy-inducing or -inhibitory activity for research in autophagy, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L1110	Microtubule-Targeted Compound Library	142 compounds
	A unique collection of 142 microtubule-targeted compounds can be used in HTS and HCS;
L1310	Cytoskeletal Signaling Pathway Compound Library	759 compounds
	A unique collection of 759 cytoskeleton-related compounds, can be used for HTS and HCS；
L1200	Epigenetics Compound Library	953 compounds
	Well-chosen 953 compounds related to epigenetic regulation for research in epigenetics, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L1380	Transcription Factor-Targeted Compound Library	695 compounds
	Well-chosen 695 compounds with unique structures targeting transcription factor;
L4000	Bioactive Compound Library	14439 compounds
	A collection of 14439 small molecule compounds with validated activity for high throughput screening (HTS), high content screening (HCS), cell induction, and target identification;
L2120	Anti-Cancer Clinical Compound Library	2545 compounds
	A unique collection of 2545 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS);
L2000	Inhibitor Library	8328 compounds
	A unique collection of 8328 inhibitors for research in cell signaling, high throughput screening (HTS) and high content screening (HCS) for new drugs;
L1710	Anti-COVID-19 Compound Library	1133 compounds
	A unique collection of 1133 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents；
L2160	Anti-Cancer Active Compound Library	3188 compounds
	A unique collection of 3188 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L1800	Anti-Infection Compound Library	2938 compounds
	A unique collection of 2938 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc;
L2151	Chemotherapy Drug Library	48 compounds
	48 Chemotherapeutic drugs that can be used for high-throughput and high-content screening.
L2130	Anti-Cancer Metabolism Compound Library	1268 compounds
	A unique collection of 1268 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);
L2110	Anti-Cancer Approved Drug Library	1779 compounds
	A unique collection of 1779 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);
L2192	Anti-Pancreatic Cancer Compound Library	2238 compounds
	A unique collection of 2238 pancreatic cancer related compounds can be used in HTS and HCS;
L3700	JAK-STAT Compound Library	252 compounds
	A unique collection of 252 JAK/STAT signaling targeted compounds for high throughput and high content screening;
L3500	Histone Modification Compound Library	469 compounds
	A unique collection of 469 histone modification related compounds for high throughput screening (HTS) and high content screening (HCS);
L2700	Adrenergic Receptor-Targeted Compound Library	193 compounds
	A unique collection of 193 bioactive compounds specifically targeting adrenergic receptors, effective tool for screening new drugs or new target identification;
L6500	Microbial Natural Product Library	550 compounds
	A unique collection of 550 microbial natural products for high throughput screening (HTS) and high content screening (HCS);
L6720	Anti-COVID-19 Traditional Chinese Medicine Compound Library	1147 compounds
	A unique collection of 1147 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening；
L6700	Anti-Tumor Natural Product Library	1772 compounds
	A unique collection of 1772 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L9410	Covalent Inhibitor Library	1920 compounds
	A unique collection of 1920 covalent Inhibitors and other molecules with common warheads like chloroacetyl，2-Chloropropionyl，Acryloyl，sulfonyl fluoride, alkyne，acrylamide, ketocarbonyl，disulfide bond, etc.
L9400	PPI Inhibitor Library	485 compounds
	A unique collection of 485 PPI-related compounds for drug screening;
L8710	Cuproptosis Compound Library	400 compounds
	TargetMol’s Cuproptosis Compound Library is a collection of 400 compounds related to copper-dependent death that can be used to study its mechanism and related diseases.
L8700	Ferroptosis Compound Library	779 compounds
	A unique collection of 779 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study；
L9411	Cysteine Covalent Library	70 compounds
	The cysteine covalent library contains 70 compounds.
L9420	Exosome Compound Library	76 compounds
	76 exosome-related compounds that can be used for high-throughput and high-content screening.
L8600	Ubiquitination Compound Library	210 compounds
	A unique collection of 210 ubiquitination related small chemicals can be used for high throughput and high content screening；
L8800	Drug-Fragment Library	1119 compounds
	1119 drug fragments，a must-have tool for FBDD;
L9810	Anti-Fibrosis Compound Library	1155 compounds
	A unique collection of 1155 potential anti-fibrosis compounds, can be used in HTS and HCS;
L9610	Cyclic Peptide Library	55 compounds
	55 species of cyclic peptide molecules for high-throughput and high-content screening;
L2200	Tyrosine Kinase Inhibitor Library	1016 compounds
	A unique collection of 1016 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases;
L2400	Endocrinology-Hormone Compound Library	784 compounds
	A unique collection of 784 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs;
L5300	Mitochondria-Targeted Compound Library	812 compounds
	A unique collection of 812 promising or approved mitochondria-targeted compounds including Idebenone, the only approved drug targeting mitochondria, for research in mitochondrial medicine;
L5400	Anti-Cardiovascular Disease Compound Library	1408 compounds
	A unique collection of 1408 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS);
L6010	Natural Product Library	3685 compounds
	A unique collection of 3685 natural products for high throughput screening (HTS) and high content screening (HCS);
L3900	DNA Damage & Repair Compound Library	910 compounds
	A unique collection of 910 DNA Damage & Repair related compounds for high throughput screening (HTS) and high content screening (HCS);
L6150	Covalent Natural Product Library	583 compounds
	Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening.
L5500	Toxic Compound Library	262 compounds
	A unique collection of 262 toxic substances for high throughput screening (HTS) and high content screening (HCS);
L4150	Featured Novel Bioactive Compound Library	989 compounds
	It is well-selected from Bioactive compound library Plus (D7800), from which 1-15 compounds with the highest scores (activity value, pharmacological properties, structure-diversity, etc.) were chosen. This library consis...
L4900	Cardiotoxicity Compound Library	131 compounds
	A unique collection of 131 cardiotoxicity inducing compounds for toxicological study;
L7110	Anti-Hypertension Compound Library	678 compounds
	678 hypertension-related small molecules for high-throughput and high-content screening.
L7200	Calcium Channel Compound Library	140 compounds
	A unique collection of 140 calcium channel blockers and agonists for high throughput and high content screening;
L7300	Potassium Channel Blocker Library	152 compounds
	A unique collection of 152 potassium channel blockers and agonists for high throughput and high content screening;
L7900	Osteogenesis Compound Library	317 compounds
	A unique collection of 317 osteogenesis related compounds for high throughput and high content screening;
L7500	Coagulation and Anticoagulation Compound Library	144 compounds
	A unique collection of 144 procoagulation and anticoagulation related compounds for high throughput screening (HTS) and high content screening (HCS);
L7820	High Solubility Micro Fragment Library	1081 compounds
	The compound library of highly soluble micro-fragments consists of 1081 low-molecular-weight fragments.
L9830	Anti-Parkinson's Disease Compound Library	857 compounds
	A unique collection of 857 compounds with anti-PD activities or acting on main drug targets of PD can be used for HTS and HCS.
L2630	Neuronal Differentiation Compound Library	672 compounds
	672 compounds related to neuronal differentiation, suitable for the drug development of nervous system disease.
L6610	Anti-infective Natural Product Library	1060 compounds
	A unique collection of 1060 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS);
L9210	Pediatric Drug Library	972 compounds
	A unique collection of 972 pediatric drugs for high-throughput screening and high-content screening.
L6820	Tobacco Monomer Library	747 compounds
	A unique collection of 747 tobacco monomer compounds for high throughput screening and high content screening;
L6620	Antiparasitic Natural Product Library	253 compounds
	A unique collection of 253 natural products with antiparasitic activity, a powerful tool for high throughput screening (HTS) and high content screening (HCS);
L6400	Marine Natural Product Library	144 compounds
	A unique collection of 144 marine natural products for high throughput screening (HTS) and high content screening (HCS);
L2196	Anti-Ovarian Cancer Compound Library	1867 compounds
	A unique collection of 1867 compounds with anti-ovarian cancer therapeutic activity, can be used for anti-ovarian cancer drug discovery and pharmacological study;
L2194	Anti-Colorectal Cancer Compound Library	1545 compounds
	1545 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening.
L9230	ReFRAME Related Library	3210 compounds
	A unique collection of 3210 compounds for high-throughput screening and high-content screening,
L9850	Orally Active Compound Library	2427 compounds
	A unique collection of 2427 of orally active compounds for high-throughput screening and high-content screening.
L2195	Anti-Prostate Cancer Compound Library	2070 compounds
	2070 compounds associated with prostate cancer that can be used for high-throughput and high-content screening.
L7840	High Solubility FragLite Fragment Library	796 compounds
	The highly soluble halogenated fragment library contains 796 halogenated fragment compounds.
L7830	High Solubility Pharmacophore Fragment Library	985 compounds
	High Solubility Pharmacophore Fragment library contains 985 fragment small molecules.
L6030	Natural Product Derivatives Library for CADD	163000 compounds
	Large quantity: contains 163,000 natural product derivatives and the number is continuously updating;
L6120	Flavonoid Natural Product Library	477 compounds
	A unique collection of 477 flavonoids can be used for high throughput and high content screening；
L5600	Mini Scaffold Library	5000 compounds
	Diversity: Selected from 1,600,000 drug-like compounds covering rich chemical scaffolds, 5000 compounds representing 5000 scaffolds；
L2600	Neuronal Signaling Compound Library	2540 compounds
	A unique collection of 2540 compounds targeting CNS signaling for high throughput screening (HTS) and high content screening (HCS) for new drugs;
L1010	FDA-Approved & Pharmacopeia Drug Library	3157 compounds
	3157 compounds from marketed drugs for high throughput screening (HTS) and high content screening (HCS);
L1100	Protease Inhibitor Library	343 compounds
	A unique collection of 343 protease and proteasome inhibitors for research in chemical genomics, and drug screening;
L1020	EMA Approved Drug Library	657 compounds

L2100	Anti-Cancer Compound Library	7234 compounds
	A unique collection of 7234 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);
L1720	Nucleotide Compound Library	334 compounds
	A unique collection of 334 nucleoside and nucleotide analogues, can be used for research and development of anti-viral, anti-tumor, anti-fungal, and anti-depressive drugs;
L6230	Miao medicine Compound Library	534 compounds
	A unique collection of 534 compounds featuring natural product molecules derived from Miao medicine that can be used for high-throughput and high-content screening.
L6810	Traditional Chinese Medicine Monomer Library	2755 compounds
	A unique collection of 2755 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism；
L6710	Anti-Inflammatory Traditional Chinese Medicine Compound Library	1246 compounds
	A collection of 1246 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study；
L7700	Neural Regeneration Compound Library	524 compounds
	A unique collection of 149 neuroregeneration related compounds for high throughput and high content screening;
L6600	Anti-Gastroenteritis Natural Product Library	219 compounds
	A unique collection of 219 natural products related to gastroenteritis for high throughput screening (HTS) and high content screening (HCS);
L6300	Food as Medicine Compound Library	1290 compounds
	A unique collection of 1290 compounds from food as medicine for high throughput and high content screening;
L6160	RO5 Drug-like Natural Product Library	2703 compounds
	A unique collection of 2703 natural product monomers that meet the "Lipinski's Rule of Five", a powerful tool for HTS and HCS screening;
L9840	Anti-Alzheimer's Disease Compound Library	986 compounds
	A unique collection of 986 compounds with anti-AD activities or acting on main drug targets of AD can be used for HTS and HCS.
L9300	Macrocyclic Compound Library	210 compounds
	210 macrocyclic compounds of known activity for high-throughput, high-content screening;
L9600	Peptide Compound Library	791 compounds
	791 peptides can be used in peptide drug development and signaling transduction and mechanism study;
L9100	Phosphatase Inhibitor Library	79 compounds
	A collection of 79 phosphatase inhibitors with known activity;
L9200	Drug Repurposing Compound Library	4541 compounds
	A unique collection of 4541 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);
L9500	Target-Focused Phenotypic Screening Library	1796 compounds
	A unique collection of 1796 annotated bioactive compounds with clear targets, suitable for phenotypic screening；
L9820	Beta-Lactam Compound Library	97 compounds
	A unique collection of 97 beta-lactam compounds, can be used in HTS and HCS;
L2550	Glutamine Metabolism Compound Library	565 compounds
	A unique collection of 565 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and ...
L2520	Glycometabolism Compound Library	702 compounds
	702 glycometabolism-related comounds, can be used for HTS and HCT;
L2510	Lipid Metabolism Compound Library	492 compounds
	A unique collection of 492 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).
L2540	Gut Microbial Metabolite Library	607 compounds
	A unique collection of 607 gut microbial metabolites which can be used for HTS and HCS;
L2800	Serotonin Receptor-Targeted Compound Library	268 compounds
	A unique collection of 268 compounds targeting serotonin receptors for high throughput screening and high content screening;
L2300	Ion Channel Inhibitor Library	931 compounds
	A unique collection of 931 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery;
L2900	Oxidation-Reduction Compound Library	1264 compounds
	1264 small molecule compounds with pro-oxidant or anti-oxidant activity for high-throughput and high-content screening.
L2530	Mouse Metabolite Compound Library	218 compounds
	A unique collection of 218 mouse metabolites, which can be used for HTS and HCS;
L3510	Methylation Compound Library	128 compounds
	128 methylation-related compounds that can be used for high-throughput and high-content screening.
L3300	Histamine & Melatonin Receptor-Targeted Compound Library	153 compounds
	A unique collection of 153 compounds targeting histaminergic receptor and melatonin receptor for high throughput screening (HTS) and high content screening (HCS) for new drugs;
L4400	Antibiotics Library	692 compounds
	A unique collection of 692 compounds with antibiotic activity for new antibacterial drug screening;
L4100	TGF-beta/Smad Compound Library	184 compounds
	A unique collection of 184 TGF-beta/Smad signaling targeted compounds for high throughput and high content screening;
L3100	Hematopoietic Toxicity Compound Library	101 compounds
	A unique collection of 101 compounds with defined hematopoietic toxicity for high throughput and high content drug screening;
L6110	Alkaloid Natural Product Library	464 compounds
	A unique collection of 464 natural alkaloids can be used for high throughput and high content screening；
L6100	Polyphenolic Natural Product Library	635 compounds
	A unique collection of 635 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS);
L5510	Drug-induced Liver Injury (DILI) Compound Library	1001 compounds
	A unique collection of 1001 hepatotoxicity causing compounds, a powerful tool for drug toxicity study, can be used for HTS and HCS screening；
L4600	Selected Plant-Sourced Compound Library	3048 compounds
	A unique collection of 3048 plant-sourced compounds that derived from 277 plant species for high throughput screening (HTS) and high content screening (HCS);
L4500	Anti-Fungal Compound Library	252 compounds
	A unique collection of 252 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.
L6130	Terpene Natural Product Library	516 compounds
	A unique collection of 516 natural terpenes and terpenoids can be used for high throughput and high content screening；
L4520	Anti-Bacterial Compound Library	904 compounds
	A unique collection of 904 antibacterial bioactive compounds, a powerful tool for antibacterial drug development;
L8200	Anti-Aging Compound Library	3279 compounds
	A unique collection of 3279 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS);
L8300	Chromatin Modification Compound Library	250 compounds
	A unique collection of 250 compounds targeting chromatin remodeling pathway for high throughput screening (HTS) and high content screening (HCS);
L9000	Apoptosis Compound Library	1760 compounds
	A unique collection of 1760 apoptosis-related compounds for apoptosis research, research in tumorigenesis, and anti-cancer drug screening;
L8000	Stem Cell Differentiation Compound Library	1197 compounds
	A unique collection of 1197 stem cell differentiation signaling targeted compounds for high throughput and high content screening;
L8100	Cell Cycle Compound Library	677 compounds
	A unique collection of 677 cell cycle related compounds for high throughput screening (HTS) and high content screening (HCS);
L7850	High Solubility 3D Diversity Fragment Library	1079 compounds
	The library of highly soluble 3D structural diversity fragments contains 1079 compounds.
L2610	Neurotransmitter Receptor Compound Library	1513 compounds
	A unique collection of 1513 neurotransmitter receptor compounds, can be used for HTS and HCS screening；
L8720	Pyroptosis Compound Library	1066 compounds
	1066 types of active small molecules associated with pyroptosis for high-throughput and high-content screening.
L2560	Metabolism Compound Library	2320 compounds
	A unique collection of 2320 metabolic pathway-related bioactive small molecule compounds for high-throughput, high-content screening.
L6220	Traditional Mongolian Medicine Compound Library	950 compounds
	A collection of 950 natural product molecules originated from Mongolian medicine, which can be used for high-throughput and high-content screening.
L2570	Human Metabolite Library	4454 compounds
	A unique collection of 4454 human metabolites for high-throughput, high-content screening.
L9900	Inactive Ingredient Library	182 compounds
	A Collection of 182 inactive ingredients from FDA-approved drugs.
L9001	Food Additive Library	425 compounds
	425 food additives;
DF4600	Drug-like natural compound library	522 compounds

DF4500	Diversity Core Library Part1	50000 compounds

DO2200	Covalent inhibitors Library	12000 compounds

L9700	Endoplasmic Reticulum Stress Compound Library	193 compounds
	A unique collection of 193 endoplasmic reticulum stress (ER stress) related compounds used for high throughput screening (HTS) and high content screening (HCS);
L7600	Chemokine Inhibitor Library	59 compounds
	A unique collection of 59 chemokines or chemokine receptors targeted compounds for high throughput and high content screening;
L1580	GPCR Compound Library Plus	338 compounds
	Well-chosen 338 GPCR targeting compounds with unique structures;
L2180	Anti-Cancer Compound Library Plus	1468 compounds
	Well-chosen 1468 anti-tumor compounds with unique structures;
L1500	GPCR Compound Library	1940 compounds
	A unique collection of 1940 GPCR-active agents for high throughput screening and high content screening for GPCR drug discovery, and new GPCR target identification and research;
L4200	FDA-Approved Drug Library	1729 compounds
	A unique collection of 1729 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);
L4700	Immunology/Inflammation Compound Library	4720 compounds
	A unique collection of 4720 anti-inflammation compounds effective for high throughput screening and high content screening.
L1700	Anti-Viral Compound Library	1040 compounds
	A unique collection of 1040 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;
L3980	DNA Damage and Repair Compound Library Plus	667 compounds
	Well-chosen 667 compounds with unique structures targeting DNA damage & repair;
L1300	PI3K-AKT-mTOR Compound Library	420 compounds
	A unique collection of 420 compounds targeting PI3K/Akt/mTOR signaling for research in PI3K/Akt/mTOR signaling, and drug discovery in diseases involved with PI3K/Akt/mTOR signaling;
L1400	MAPK Inhibitor Library	365 compounds
	A unique collection of 365 compounds targeting MAPK signaling for drug discovery in MAPK related diseases;
L1520	Membrane Protein-targeted Compound Library	4229 compounds

L1510	Nuclear Receptor Compound Library	531 compounds
	A unique collection of 531 nuclear receptor signaling targeted compounds for high throughput and high content screening;
L1600	Kinase Inhibitor Library	2700 compounds
	A unique collection of 2700 kinase inhibitors/regulators for high throughput screening and high content screening for drug discovery in kinase related diseases;
L4010	Bioactive Compounds Library Max	22555 compounds
	A collection of 22555 bioactive compounds for high-throughput screening, high-content screening, cell induction and target identification.
L2150	Anti-Cancer Drug Library	3080 compounds
	A unique collection of 3080 anticancer drugs for high throughput screening (HTS) and high content screening (HCS);
L4020	NO PAINS Compound Library	9384 compounds
	TargetMol created the L4020 NO-PAINS Compound Library that applied the PAINS filter, remaining 9384 small molecules that are suitable for new drug development, signaling pathway research, drug repurposing and other resea...
L1610	FDA-Approved Kinase Inhibitor Library	263 compounds
	A unique collection of 263 kinase inhibitors/regulators for specific targeting of kinases, ready for high-throughput screening and high-content screening.
L2190	Anti-Lung Cancer Compound Library	1702 compounds
	A unique collection of 1702 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study；
L2140	Cancer Cell Differentiation Compound Library	406 compounds
	A unique collection of 406 cancer cell differentiation inducing compounds for high throughput and high content screening;
L1900	Anti-Diabetic Compound Library	683 compounds
	A unique collection of 683 diabetes related compounds;
L2152	Targeted Therapy Drug Library	119 compounds
	119 tumor-targeted drugs that can be used for high-throughput and high-content screening.
L2170	Immuno-Oncology Compound Library	449 compounds
	A unique collection of 449 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening；
L2191	Anti-Breast Cancer Compound Library	1939 compounds
	A unique collection of 1939 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study；
L4710	Nonsteroidal Anti-Inflammatory Compound Library	521 compounds
	521 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening.
L5800	Drug Metabolite/Impurity Library	197 compounds
	A unique collection of 197 drug isomers/metabolites for high throughput screening (HTS) and high content screening (HCS);
L5900	CNS-Penetrant Compound Library	509 compounds
	A unique collection of 509 CNS-Penetrant compounds for high throughput screening (HTS) and high content screening (HCS);
L5100	Fluorochemical Library	574 compounds
	A unique collection of 574 fluorochemicals that can be used for high through-put screening (HTS) and high content screening (HCS);
L4800	Angiogenesis related Compound Library	1353 compounds
	A unique collection of 1353 proangiogenic and antiangiogenic compounds for new targets identification, research in mechanisms of angiogenesis, and high throughput screening (HTS) and high content screening (HCS);
L4510	Anti-Parasitic Compound Library	419 compounds
	419 well-chosen unique anti-parasitic small molecules;
L5200	Anti-Metabolism Disease Compound Library	1544 compounds
	A unique collection of 1544 metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS);
L6750	PBCRBS Traditional Chinese Medicine Compound Library	580 compounds
	A unique collection of 580 compounds derived from traditional Chinese medicines (TCMs) for promoting blood circulation and removing blood stasis.
L6210	Tibetan medicine Compound Library	747 compounds
	A collection of 747 natural product molecules originated from Tibetan medicine, which can be used for high-throughput and high-content screening.
L6800	Chinese Pharmacopoeia Natural Product Library	2051 compounds
	A unique collection of 2051 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study;
L6140	Saccharide and Glycoside Natural Product Library	362 compounds
	A unique collection of 362 saccharides and glycosides compounds can be used for HTS and HCS；
L8500	HIF-1 Signaling Pathway Compound Library	1336 compounds
	A unique collection of 1336 HIF-1 related small chemicals can be used for drug discovery in ischemic disease and cancer and related mechanism studies；
L8400	Hematonosis Compound Library	514 compounds
	A unique collection of 514 compounds related to hematologic diseases for high throughput screening (HTS) and high content screening (HCS);
L7100	Anti-Obesity Compound Library	2247 compounds
	A unique collection of 2247 anti-obesity compounds for high throughput and high content screening;
L6900	Rare Natural Product Library	178 compounds
	A unique collection of 178 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);
L7400	Sodium Channel Blocker Library	118 compounds
	A unique collection of 118 sodium channel blockers and agonists for high throughput and high content screening;
L8110	Reprogramming Compound Library	1813 compounds
	A unique collection of 1813 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening.
L7800	High Solubility Fragment Library	2728 compounds
	Structurally diverse, medicinally active, and unique chemistry (strong IP potential);
L2910	Antioxidant Compound Library	1314 compounds
	Oxidative stress reflects an imbalance between the systemic manifestation of reactive oxygen species (ROS) and a biological system's ability to readily detoxify the reactive intermediates or repair the resulting damage. ...
L2620	Anti-Neurodegenerative Disease Compound Library	2154 compounds
	A unique collection of 2154 compounds related to neurodegenerative diseases can be used for HTS or HCS；
L3400	Clinical Compound Library	3404 compounds
	A unique collection of 3404 compounds in clinical trial phases for high throughput screening (HTS) and high content screening (HCS);
L3410	Preclinical Compound Library	701 compounds
	A unique collection of 701 preclinical compounds for high throughput screening (HTS) and high content screening (HCS);
L2501	Human Endogenous Metabolite Compound Library Plus	1283 compounds
	A unique collection of 1283 endogenous metabolism-related compounds for research in endogenous metabolism-related diseases and drug screening.
L2500	Human Endogenous Metabolite Library	499 compounds
	A collection of 499 selected human endogenous metabolites for high throughput and high content screening.
L3800	NF-κB Signaling Compound Library	729 compounds
	A unique collection of 729 compounds targeting NF-κB signaling for high throughput screening and high content screening;
L4300	Wnt/Hedgehog/Notch Compound Library	237 compounds
	A unique collection of 237 Wnt/Hedgehog/Notch signaling targeted compounds for high throughput and high content screening;
L3600	Cytokine Inhibitor Library	604 compounds
	A unique collection of 604 compounds targeting cytokine signaling for high throughput screening and high content screening for drug discovery;
L9860	Antidepressant Compound Library	1163 compounds
	1163 compounds associated with depression that can be used for high-throughput and high-content screening
L6740	Anti-Colorectal Cancer Traditional Chinese Medicine Compound Library	382 compounds
	A collection of 382 TCM monomers with anti-colorectal activity. An effective tool for drug development and pharmacological studies.
L6200	The Yao nationality medicine Library	221 compounds
	A collection of 221 natural product molecules originated from Yao medicine, which can be used for high-throughput and high-content screening.
L6730	Anti-virus Traditional Chinese Medicine Monomer Library	268 compounds
	A collection of 268 TCM monomers with anti-virus activity. An effective tool for drug development and pharmacological studies.
L2193	Anti-Liver Cancer Compound Library	1787 compounds
	1787 species of compounds related to liver cancer that can be used in anti-liver cancer drug development and pharmacological studies.
L2521	Glycolysis Compound Library	555 compounds
	555 glycolysis-related active compounds for high-throughput and high-content screening.
L7870	Carboxylic Acid Fragment Library With Solubility	1806 compounds

L2010	Highly Selective Inhibitor Library	575 compounds
	A collection of 575 highly selective inhibitors
L6000	Natural Product Library for HTS	4441 compounds
	A unique collection of 4441 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can...